Kim van der Elst

Research Staff Other

Research groups

Clinical pharmacy research

Research aim

The mission of the clinical pharmacy program is to explain, predict and improve patients’ response to pharmacotherapeutic treatment using clinical pharmacological and clinical pharmacoepidemiological approaches.

Go to group

Recent publications

Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease Coco Dekkers, Erin H Smeijsters, Mohsin El Amrani, Constance den Hartog Jager, Kim C M van der Elst, Matthijs van Luin, Chantal van Luijk, Daphne S Bakker, Alwin D R Huitema, Marlies de Graaf, Femke van Wijk, Marjolein S de Bruin-Weller
Clinical and Experimental Allergy, 2025, vol. 55, p.1156-1160
Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation Linde Dekker, Coco de Koning, Laura Nijstad, Kim van der Elst, Rick Admiraal, Birgitta Versluijs, Jaap-Jan Boelens, Alwin Huitema, Caroline Lindemans, Stefan Nierkens
Blood Neoplasia, 2024, vol. 1
Evaluation of standard fludarabine dosing and corresponding exposures in infants and young children undergoing hematopoietic cell transplantation Julia Möhlmann, Lisanne van der Ploeg, Jurgen Langenhorst, Tim Bognàr, Kim van der Elst, Marc Bierings, Alwin Huitema, Aurelia de Vries Schultink, Caroline Lindemans
Bone Marrow Transplantation, 2024, vol. 60, p.241–243
Association of Lamotrigine Plasma Concentrations With Efficacy and Toxicity in Patients With Epilepsy Ze Ning Lee, Merel van Nuland, Tim Bognàr, Frans S.S. Leijten, Kim C.M. van der Elst
Therapeutic drug monitoring, 2024, vol. 46, p.642-648
Busulfan exposure target attainment in adults undergoing allogeneic hematopoietic cell transplantation T Bognàr, I H Imke Bartelink, K C M van der Elst, J S Kingma, E H Smeijsters, C A Caroline Lindemans, A C G Toine Egberts, J H E Kuball, M A de Witte, A H M de Vries Schultink, A Lalmohamed
Transplantation and Cellular Therapy, 2024, vol. 30, p.1007.e1-1007.e10
Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary Pneumocystis jirovecii co-infection Jos L M L le Noble, Norbert Foudraine, Kim C M van der Elst, Sander Bouwman
International Journal of Clinical Pharmacology and Therapeutics, 2023, vol. 61, p.525-530